Pharmaceutical Development and Technology 2014-09-01

Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats.

An Zhou, Tao Lu, Lei Wang, Chuanhua Lu, Lina Wang, Maolin Wan, Hongfei Wu

Index: Pharm. Dev. Technol. 19(6) , 743-7, (2014)

Full Text: HTML

Abstract

This study investigated the potential of targeted intestinal lymphatic transport of puerarin via a lipid formulation approach. Three formulations of PEG nanoemulsion, nanosuspension and an oil suspension containing puerarin were examined with the lymph-cannulated anaesthetized rat model. Plasma and lymph samples were analyzed by HPLC. Lymph triglyceride was measured using an enzymatic colorimetric technique. After 8 h, the total administered dose accumulated in the thoracic lymph duct was analyze. Nanoemulsion, nanosuspension and oil suspension was 0.065 ± 0.006%, 0.137 ± 0.018%, 0.021 ± 0.002% of the administered dose, respectively. In nanoemulsion, nanosuspension and oil suspension group, the systemic bioavailability of oral puerarin was 11%, 16% and 11% for lymph-cannulated rats, 41%, 67% and 18% for control rats. Absorption into the intestinal lymph should thus contribute to ∼30%, 51% and 7% of the systemic bioavailable puerarin. This data indicated that lipid-based nano drug formulation produced higher lymph concentrations of puerarin than oil suspension. The nanosuspension formulation may be considerable in terms of increased local concentrations in lymphoid tissue.


Related Compounds

Related Articles:

The transgenic Arabidopsis plant system, pER8-GFP, as a powerful tool in searching for natural product estrogen-agonists/antagonists.

2005-07-01

[J. Nat. Prod. 68 , 971-3, (2005)]

UFLC-MS/MS method for simultaneous determination of luteolin-7-O-gentiobioside, luteolin-7-O-β-D-glucoside and luteolin-7-O-β-D-glucuronide in beagle dog plasma and its application to a pharmacokinetic study after administration of traditional Chinese medicinal preparation: Kudiezi injection.

2013-01-01

[J. Pharm. Biomed. Anal. 72 , 127-33, (2013)]

Glucose uptake enhancing activity of puerarin and the role of C-glucoside suggested from activity of related compounds.

2010-08-01

[Bioorg. Med. Chem. Lett. 20 , 4333-6, (2010)]

Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.

2013-01-01

[Pharm. Dev. Technol. 18(5) , 1051-7, (2013)]

Identification and assay of 3'-O-methyltaxifolin by UPLC-MS in rat plasma.

2012-12-12

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 911 , 34-42, (2012)]

More Articles...